Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-04-06-Speech-3-356-750"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-04-06"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20110406.29.3-356-750"2
lpv:hasSubsequent	lp_eu:2011-04-06-Speech-3-357-0002
lpv:speaker	lp:Marielle de Sarnez2
lpv:spokenAs	member; INTA (2009-07-16--2012-01-18)3 substitute; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 vice-chair; ALDE (2009-07-14--2014-06-30)3 substitute; AFET (2009-07-16--2012-01-18)3 unknown; Mouvement Démocrate (2009-07-14--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; Delegation for relations with the countries of the Andean Community (2009-09-16--2014-06-30)3
lpv:translated text	"We did not want the statement that docosahexaenoic acid (DHA), a fatty acid found in breast milk, was good for the normal visual development of infants to appear on products for infants. There is no scientific data to support the opinion given by the European Food Safety Authority (EFSA), on which the European Commission relied to propose the authorisation to display this claim on food intended for infants. It was therefore necessary to apply the precautionary principle and, hence, not to authorise this claim. Unfortunately, by just 8 votes, Parliament decided to accept the Commission’s proposal. This puts the issue of the independence and of the accuracy of the EFSA’s assessments back on the table."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph